title: 1,25-Dihydroxyvitamin D(3) may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: comment on the article by Colin et al.
authors.forename: Rui-Xue
authors.initials: RX
authors.lastname: Leng
authors.forename: Hai-Feng
authors.initials: HF
authors.lastname: Pan
authors.forename: Dong-Qing
authors.initials: DQ
authors.lastname: Ye
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism; D020381:Interleukin-17 / Q000378:metabolism; D010024:Osteoporosis / Q000139:chemically induced* / Q000517:prevention & control*; D016176:T-Lymphocyte Subsets / Q000187:drug effects* / Q000378:metabolism; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D020381:Interleukin-17; D016753:Interleukin-10; D014807:Vitamin D; C097949:1,25-dihydroxyvitamin D